EP4683692A1 - Breath actuated dry powder inhaler - Google Patents
Breath actuated dry powder inhalerInfo
- Publication number
- EP4683692A1 EP4683692A1 EP24713587.4A EP24713587A EP4683692A1 EP 4683692 A1 EP4683692 A1 EP 4683692A1 EP 24713587 A EP24713587 A EP 24713587A EP 4683692 A1 EP4683692 A1 EP 4683692A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- planar
- dose
- chamber
- inhaler
- housing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/001—Particle size control
- A61M11/002—Particle size control by flow deviation causing inertial separation of transported particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0043—Non-destructive separation of the package, e.g. peeling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
- A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
- A61M15/0048—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged in a plane, e.g. on diskettes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2206/00—Characteristics of a physical parameter; associated device therefor
- A61M2206/10—Flow characteristics
- A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows
Definitions
- the known dry powder inhaler provides various advantages. By providing the polygonal sidewall with at least six straight sides it appears that the contact surface area between circulating particles and the wall is reduced such that a reduction of adhesion of powder against the wall parts is obtained.
- the collision angle i.e. the angle between the imaginary extension of the sides, has such a value, i.e. 60° or smaller, that the magnitude of the compaction force is also reduced and a higher residual particle velocity after collision is obtained.
- the many air flows through the air supply channels furthermore create a continuous air barrier for the smaller particles which, in conjunction with the reduced ratio of the centrifugal to drag force, keeps them away from the cylindrical classifier wall and prevents that they contribute to the adhesion and compaction against the classifier sidewall.
- the powder channel is wider than the air supply channels the risk of clogging of the powder channel is reduced, but the symmetry of the air circulation in the chamber is negatively influenced.
- the number of air supply channels is large enough so that the air flowing through the air supply channels into the chamber corrects for the asymmetry of the air circulation in the chamber such that de-agglomerated powder can be dispensed from the inhaler correctly.
- a sealed dose compartment is applied.
- the sealed dose compartment is a blister-shaped pocket sealed with a removable cover foil.
- the blister-shaped pocket is included in a stack with the cover foil extending out of the inhaler as a pull off portion.
- the resulting unit forms a disposable unit for a single dose.
- a single dose of the active ingredient may be divided over a plurality of dose compartment pockets for either simultaneous or subsequent inhalation.
- Each compartment may contain the same component or mixture, or may contain different components or mixtures.
- the compartments may be loaded from a metering apparatus in the housing, but are preferably pre-filled.
- US2017/0106154 provides a dry powder inhaler which does not need blister capsules for storing the powder formulation. To that aim, the document proposes a dry powder inhaler wherein during storage of the powder formulation the powder formulation is in direct contact with the housing. Since the powder formulation is in direct contact with the housing of the dry powder inhaler during storage of the dry powder inhaler, i.e.
- the dry powder inhaler before the dry powder inhaler is used for inhaling a dry powder medicament, and since the dry powder inhaler contains only a single dose of powder formulation, the dry powder inhaler according to this disclosure does not need an extra storing device, e.g. in form of a blister capsule or in form of a foil-faced container for storing the powder formulation before the dry powder inhaler is prepared for usage.
- an extra storing device e.g. in form of a blister capsule or in form of a foil-faced container for storing the powder formulation before the dry powder inhaler is prepared for usage.
- a breath actuated dry powder inhaler that is defined by the features of claim 1.
- An aspect of the invention provides a breath actuated dry powder inhaler, said inhaler comprising a substantially planar housing built up of a stack of substantially planar elements, said planar elements including a bottom plate, an intermediate plate and a top plate, said planar elements being parallel to each other, at least one planar element being provided with projections, that in the stack form a substantially disc shaped air circulation chamber for de-agglomeration of entrained powdered medicament (from the dose compartment) using the energy of the inspiratory air stream, a plurality of air supply channels, an air supply region for a powder flow and a discharge channel of the inhaler, the chamber having a substantially polygonal sidewall extending about a central axis between top and bottom walls of the chamber, the central axis extending transversely to the bottom plate, the height of the chamber being smaller than its diameter, the plurality of air supply channels being disposed about the circumference of the chamber, which channels extend from an air inlet and which channels enter the chamber substantially tangentially to its sidewall
- the resulting inhaler can be made compact, and e.g. structurally rigid, and can provide very effective reliable powder delivery.
- the inhaler can be made reusable and (more) durable, and can be less harmful to the environment.
- two of the three plates can provide (i.e. act as) guiding means for guiding the planar dose compartment between respective operating positions.
- the third plate can serve for air conduction over the classifier discharge hole and improves structural integrity of the inhaler, counteracting deformation of the other plates, improving reliability of sliding movement of the planer dose compartment.
- one of the plates of the housing e.g. the bottom plate
- a bottom of the planar dose compartment can protrude below e.g. the bottom plate of the plate stack, so that the dose compartment can provide additional volume for holding a dose of dry powder.
- Fig. 4C a top view of the embodiment of Fig. 3 after assembly
- Fig. 5A a back view of the embodiment of Fig. 3, with the plate stack shown in cross-section, before assembly of the planar dose compartment;
- Fig. 5B a back view of the embodiment of Fig. 3, with the plate stack shown in cross-section, after assembly of the planar dose compartment;
- Fig. 6A an exploded view, similar to Fig. 1, of another embodiment of the present invention.
- Fig. 6B a bottom view of a planar dose compartment of the embodiment of Fig. 6A;
- Fig. 7 A a top view of the embodiment of Fig. 6A;
- Fig. 7C a top view of the bottom plate of the embodiment of Fig. 6A;
- Fig. 7D a top view of the planar dose compartment of the embodiment of Fig. 6A;
- Fig. 7E a back view of the housing of the embodiment of Fig. 6A;
- Fig. 8A an opened top view, similar to Fig. 7B, of a further embodiment of the inhaler, with the planar dose compartment in a first position
- Fig. 8B an opened top view, similar to Fig. 7B, of the further embodiment of the inhaler, with the planar dose compartment in a second position;
- Fig. 8C a top view of the bottom plate of the embodiment of Fig. 8 A;
- Fig. 8D a top view of the planar dose compartment of the embodiment of Fig. 8A
- Fig. 9 a top view of an example of an array of dose compartments
- Figure 10 schematically an opened top view of an embodiment of a breath actuated dry powder inhaler and part of the array of dose compartments shown in Fig .9;
- Fig. 11A an opened top view of the inhaler example shown in Fig. 10;
- Fig. 11B a longitudinal cross-section of a bottom plate of the inhaler example of Fig. 11 A;
- Figure 12A a back view of a stopper element of the inhaler example of Fig. 11 A.
- Figure 12B a side view of the stopper element of the embodiment of Fig. 11A.
- Figure 1 shows a breath actuated dry powder inhaler 1, comprising a single, substantially disc shaped air circulation chamber 2 for de-agglomeration of entrained powdered medicament using the energy of the inspiratory air stream.
- the chamber 2 has a polygonal sidewall 3 extending about a central axis 4 between a substantially parallel top wall (formed by a substantially planar intermediate plate 18) and bottom wall (formed by a substantially planar bottom plate 19) of the chamber 2 so that the height of the chamber is smaller than its diameter.
- the diameter of the single chamber 2 is about 25 mm, but it can in other embodiments have another value between 20 mm and 30 mm.
- the polygonal sidewall 3 has seven straight line segments or sides 5a - 5g, being formed by a surface of a respective projection 20.
- the projections 20a-20b, 20b-20c, 20c-20d, 20d-20e, 20e-20f and 20f-20g are spaced at the same distance (also called first distance) from each other so as to form a plurality of air supply channels 7 (in the embodiment shown in Figure 1 six) which have the same width and which are regularly disposed about the circumference of the chamber 2, which channels 7 extend from separate air inlets and which channels enter the chamber 2 substantially tangentially to its sidewall 3.
- Said distance, i.e. the width of the air supply channels is in the embodiment shown in Figure 1 about 1.5 mm, but can in other embodiments be between 1 and 2 mm.
- each of the air supply channels 7 can be constant but that is not required (e.g. the channels 7 can be wider at their inlet sides compared to a width at their outlet sides).
- the projections 20a and 20g are spaced at a larger distance from each other forming a powder channel 7a.
- this larger, second distance i.e. the width of the powder channel
- this larger, second distance is about three to four, preferably 3.5 times the first distance, i.e. about 5 mm, but can in other embodiments be at least twice the first distance, i.e. at least 3 mm.
- this larger, second distance i.e. the width of the powder channel
- this larger, second distance is about two to five, preferably four times the first distance (preferably at least 2 mm).
- the powder channel 7a extends from a joint air supply inlet to the powder dose region 8 of the inhaler 1.
- the chamber 2 further comprises an air outlet 9 axially extending from a (preferably circular) discharge opening 10 in the centre of the top wall of the chamber 2 and that connects to a discharge channel 12.
- the discharge channel 12 extends to a mouthpiece 13. Please note that in Figure 1 an embodiment is disclosed with seven sides, but that the invention is not limited to this number and any number of sides can be provided as long as there are more than six sides.
- the discharge channel 12 connects substantially transversely to the air outlet 9 of the chamber.
- the axis MP of the mouthpiece 13 is orientated transversely to the central axis 4 of the classifying chamber 2.
- the inhaler 1 can be assembled such that it comprises a substantially planar housing having the shape and size of a thick credit card, being constructed as e.g. a disposable unit.
- the invention is not limited to the manner in which the parts are connected to each other and that e.g. a construction with which the parts are clicked together with flexible bps or tapered pins falling in corresponding holes is also possible (see e.g. Figure 3).
- the chamber 2 is disposed in the housing such that the central axis 4 of the chamber 2 extends transversely to the bottom plate 19.
- the discharge channel 12 is disposed in the housing such that it extends in a plane parallel to the bottom plate.
- the mouthpiece 13 is provided on a peripheral edge 15 of the housing.
- the discharge channel 12 and the circulation chamber 2 extend in substantially parallel planes.
- the mouthpiece 13 discharges an aerosol cloud of de-agglomerated powder particles entrained from the air recirculation chamber 2 in a direction parallel to the longitudinal axis of the inhaler housing which coincides with the axis MP, while the axis of the classifying chamber 2 is perpendicular to the longitudinal axis of the inhaler housing 14.
- the housing is thus built up of a stack of substantially planar elements 16.
- These elements 16 include the bottom plate 19, the intermediate plate 18 and a top plate 17.
- the inhaler 1 is positioned such that top plate 18 is located above the bottom plate 19.
- the planar bottom plate 19 is provided with projections 20, that in the stack form the chamber 2, the air supply channels 7, the air supply region for the powder flow 8 and the discharge channel 12 of the inhaler 1.
- the top surface of the bottom plate 19 e.g. forms the bottom wall of the chamber 2, and carries the projections 20 that form the sides 5a- 5g.
- the free edges of the sides can be rounded off pointing towards the centre of the chamber 2 and are substantially positioned on an imaginary circle.
- the chamber 2 is closed off by the bottom surface of the intermediate plate 18, forming the top wall of the chamber 2.
- the intermediate plate 18 forms a division between a bottom plane in which the chamber 2 extends and a parallel top plane in which the discharge channel 12 extends.
- a (e.g. circular) discharge opening 10 in the intermediate plate 18 forms a passage for air and entrained, de-agglomerated medicine particles exiting the chamber through air outlet 9 extending co-axially with axis 4.
- Powder particles are thus introduced into the chamber 2 by entrainment with air entering tangentially into the chambers 2 through the powder supply channel 7a. Additional air is supplied to the chambers 2 through supply channels 7, which also enter tangentially into the chambers. This way, a circular air flow is created in the chamber 2 during inhalation and as a result of the relatively large diameter of the chamber 2 the circulation is sufficient for higher doses of medication. By distributing the relatively large number of supply channels 7 evenly about the circumference of the chamber, the circulation of the flow in the chambers 2 is further enhanced.
- the contact surface area between circulating particles and the wall is - compared to the prior art - reduced which attributes to a reduction of compaction of powder against the wall parts.
- a further reduction of compaction is obtained in that the collision angle, more detailed explained with regard to Figure 2, is maximally 30° to 45° (depending on the number of channels).
- the high number of air channels results in an improved symmetry of the flow within the classifier chamber in which the smaller particles circulate at a certain distance from the polygonal sidewall. This prevents that they do collide with the sidewall, thereby preventing adhesion and compaction against this wall.
- Flow symmetry can be further influenced by lengthening the wall 20g’ of the projection 20g forming one of the walls of the powder channel 7a. Due to the relatively wide powder channel 7a, which is at least twice as wide as the air flow channels 7 and preferably three times as wide, clogging of the powder channel 7a is strongly reduced c.q. can be prevented.
- the powder particles break up correctly, i.e. they are correctly dispersed while retention is strongly reduced, so as to improve the suitability of the inhaler for cohesive, hygroscopic and compacting powders. Furthermore, finer particles are effectively entrained with the air flow exiting the chamber 2 axially through the air outlet 9 under the action of dominant drag forces. Larger particles, including sweeper crystals used to clean deposited particles from the walls of the chamber 2, remain in the chamber 2 under the action of dominant centrifugal forces unless they break up.
- a further advantage of the inventive inhaler is that even in case the dry powder does not contain sweeper crystals the sides 5 of the chamber can remain clean.
- the discharge channel 12 has a central axis MP that extends perpendicularly to the central axis 4 of the chamber 2, the discharge 12 channel connects transversely to the central axis of the air outlet 9 of the chamber 2, which coincides with the central axis 4 of the chamber 2, it is achieved that the flow from the air outlet 9 to the discharge channel changes direction from coaxial to the chamber axis to transverse to the chamber axis before exiting the mouthpiece 13. This way, the tangential component in the flow is decreased, so that mouth deposition is reduced without the need to provide a sheath flow. This increases the efficiency of the actual deh very of medicine to the lungs.
- the powder in the dose compartment 23 may be the active ingredient or a composition of the active ingredient and one or more excipients, being either a carrier for the drug, a sweeper excipient, a dispersion enhancer, a stabiliser, or any other material suitable for adjusting the specific powder properties to the performance of the circulation chamber.
- the powder in the dose compartment 23 may be the active ingredient or a formulation with the active ingredient being e.g.
- a single dose of the active ingredient may be divided over a plurality of dose compartments pocket 23 for either simultaneous or subsequent inhalation.
- Each compartment may contain the same component or mixture, or may contain different components or mixtures.
- the compartments may be loaded from a metering apparatus in the housing, but are preferably prefilled.
- FIG. 2 another embodiment of a breath actuated dry powder inhaler 201 is shown, in which the polygonal sidewall has eleven straight line segments or sides 205a - 205k (only the sides 205a and 205k are shown for convenience of drawing), which are formed by a surface of a respective projection 220.
- the projections 220a-220b, 220b-220c, 220c-220d, 220d-220e, 220e-220f; 220f-220g; 220g-220h; 220h-220i; 220i-220j and 220j-220k are spaced at the same distance from each other so as to form a plurality of air supply channels 207 (in the embodiment shown in Figures 2 and 3 ten) which have the same width and which are regularly disposed about the circumference of the chamber.
- the projections 220a and 220k are again spaced at a larger distance from each other forming a powder channel 207a.
- Figures 3-8 show exemplary embodiments 301, 401 of improved inhalers.
- the improved inhaler 301 has a substantially planar housing built up of a stack of substantially planar elements 317, 318, 319, said planar elements including a bottom plate 319, an intermediate plate 318 and a top plate 317, said planar elements are parallel to each other.
- At least one planar element 319 (in this case the bottom plate) is provided with the projections 320, that in the stack form a substantially disc shaped air circulation chamber 302 for de-agglomeration of entrained powdered medicament using the energy of the inspiratory air stream.
- the discharge channel 312 connects substantially transversely to the air outlet 309 of the chamber 302.
- the inhaler 301 comprises a single air circulation chamber 302.
- the polygonal sidewall 303 comprises at least six straight line segments or sides, each straight line segment being spaced at the same first distance from an adjacent one forming the plurality of air supply channels 307.
- the air supply channels 307 have the same width and are regularly disposed about the circumference of the chamber 302.
- the powder channel 307a can be defined by two straight line segments which are spaced from each other at a second distance which is larger than the first distance.
- An aperture 311 can be provided in the intermediate plate 318 allowing passage of air (from an air supply area 311a between the top plate and intermediate plate, see Fig. 5) through the powder supply region 308 during inhaler operation.
- the planar element 319 that is provided with the projections 320, that in the stack form a substantially disc shaped air circulation chamber 302, can also include guide projections 319b for guiding the slidable planar dose compartment 323.
- the (preferably flat) upper side 323f of the slide plate 323a can extend in parallel with respect to an opposite surface of the intermediate plate 318 of the housing, after mounting.
- a lower side 323g of the slide plate 323a (that is faced away from the respective upper side 323f, see Fig. 5A) preferably extends in parallel with respect to an opposite surface of the lower plate 319 of the housing, after mounting. It is preferred that the upper side 323f and lower side 323g of the slide plate snuggly fit between opposite parts of the respective housing plates 318, 319 after mounting, allowing precise dose compartment positioning.
- the slide plate 323a can include an integral resilient locking finger 323h, cooperating with a locking structure/relief (e.g. retaining wall 319e) of the housing for releasably holding the slide plate 323a in its operating position.
- a locking structure 319e can be located e.g. at or near a proximal side of the housing (as in the drawings), and/or internally in the housing.
- the housing of the inhaler 301 can include a resilient locking finger, for releasably locking the planar dose compartment in its second position.
- the dose reservoir 323b of the planar dose compartment 323 is located in line with, i.e. longitudinally opposite, the powder channel 307a of the inhaler housing when the dose compartment 323 is in its second (i.e. operating) position (see Figure 4B). Also, the thus positioned dose reservoir 323b is preferably located below/opposite the air passage (aperture) 311 of the intermediate plate 318. Good results can be achieved in case the air passage 311 of the intermediate plate 318 is dimensioned such that it has a significantly smaller cross-section than (e.g.
- the air passage 311 of the intermediate plate 318 is located above a proximal section of the open upper section of the cup shaped section of the slide plate 323a (i.e. near a proximal side of the housing of the inhaler).
- a rear side (edge) of the air passage 311 is located above a rear side (edge) of the dose reservoir 323b when the dose compartment 323 is in its second position.
- the intermediate plate 318 includes an upstanding bridge section 318b, extending opposite each of the powder channel 307a and the open upper section of the cup shaped section of the slide plate 323a, for defining an air/powder passage there-below.
- a central section of the upstanding bridge section 318b can be located e.g. opposite the end stop wall opening 319d.
- a bottom side of the upstanding bridge section 318b has a generally concave shape, e.g. having both a slanted proximal section and a slanted distal section (viewed along a flow direction), with a straight section between the two slanted sections.
- the upstanding bridge section 318b is configured/arranged such that a respective slanting bottom side has about the same slope percentage as a slope of an aforementioned slanted lateral cup side 323e (if present).
- the upstanding bridge section 318b is configured/arranged such that it defines a bridge channel with opposite surfaces of a positioned slide plate 232a and the bottom plate 319, the bridge channel having a substantially constant cross-section viewed along a respective powder flow direction along the bridge section 318b. In this way, powder blockage in the bridge powder channel can be prevented.
- the slide plate 323a of the dose compartment 323 has a thickness W (measured normally with respect to the main surfaces of the housing plates 317, 318, 319, as indicated in Fig. 5B) that is the same as or a smaller than a height of the air circulation chamber 302 of the housing.
- the slide plate 323a can be dimensioned such that part of the plate protrudes externally of the inhaler housing when it is in its second position (see Figure 4B, 4C).
- the protruding slide plate part can include part the optional locking finger, and can provide a user operating member for manual handling of the slide plate 323a.
- an entry section of the inhaler housing can include slanted or curved proximal entry edges 319f, e.g. leading to said longitudinal support wall sections 319g of the bottom plate 319, allowing ease of slide plate insertion.
- an opposite edge of the intermediate plate 318 can be slanted or curved, for the same purpose.
- Figures 6-7 depict another example of an improved powder inhaler 401, including a top plate 417, intermediate plate 418, and bottom plate 419, and the respective substantially disc shaped air circulation chamber 402 (see above).
- the present example differs from the example shown in Figures 4-5 in that the slidable planar dose compartment 423 is not removable from the housing of the inhaler 401.
- the dose compartment 423 includes more than one (in this case two) dose reservoirs 423c containing separate doses DI, D2.
- the planar dose compartment 423 is preferably movable within the housing, between two of the plates (the bottom plate 419 and the intermediate plate 418) between a first operating position (see Fig. 7B) for positioning a first dose DI in a dose supply region and a second operating position (not shown) for positioning a second dose D2 in the dose supply region.
- the planar dose compartment 423 can e.g. be movable in transversal direction with respect to a longitudinal axis MP of the inhaler 401.
- the bottom plate 419 of the housing can include a (in this case rectangular) aperture 419a for receiving part of the planar dose compartment 423. Also, as is shown in Fig. 7B by arrow AF indicating an air flow, this aperture 419a can provide an air passage towards the projections 420 of the substantially disc shaped air circulation chamber 402, in each of the two positions of the planar dose compartment 423.
- the housing can include two air channels 407b to the supply channels formed between the projections 420 and bottom plate 419 and the intermediate plate 418 to the chamber 402, for receiving the air AF from the aperture 419a, the two air channels 407b being associated with the two operating positions of the dose compartment 423.
- the powder channel 407a can be located between the two air channels 407b.
- the planar dose compartment 423 preferably has a substantially rectangular shape (viewed in a top view).
- the planar dose compartment 423 includes a (flat) slide plate 423a having two dose reservoirs 423b that may e.g. be covered by one or two respective removable foils (not shown).
- the two dose reservoirs 423b extend in parallel.
- each dose reservoir 423b can extend in parallel with the planar elements 417, 418, 419 of the housing, after assembly of the inhaler.
- the substantially planar housing of the inhaler 401 and the duodose planar dose compartment 423 preferably includes cooperating guide structures for guiding lateral movement of the dose compartment 423 with respect of the housing.
- Such guide structures can include opposite side walls and/or external surfaces of the respective components 423, 418, 419, as will be appreciated by the skilled person.
- planar element 419 that is provided with the projections 420, that in the stack form a substantially disc shaped air circulation chamber 402 can also include guide projections 419b, 419c for guiding the slidable planar dose compartment 423.
- the bottom plate 419 of the housing can include opposite longitudinal guide walls 419b, that may optionally provide end stops engaging respective lateral sides of the slide plate 423a when that plate is in one of its two operation positions.
- the guide walls 419c of the housing include curved (rounded) corners for snuggly contacting curved (rounded) distal edges of the slide plate 423a when the plate 423a is positioned in one of its two operating positions.
- each of the two dose reservoirs 423b can be defined by a cup shaped section of the slide plate 423a, having a cup bottom 423c, two opposite longitudinal cup sides and two lateral opposite cup sides.
- Each cup bottom 423c is preferably located at a vertical level below a lower side of the slide plate 423a, for providing increase of dose cup volume.
- the bottom plate 419 of the inhaler’s housing can include the aforementioned aperture 419a for receiving the two cup shaped sections (i.e. respective downwardly protruding cup sides and cup bottom walls) of the planar dose compartment 423.
- releasable locking means are provided for releasably locking the planar dose compartment 423 to the housing when it is in one of its two powder delivery positions.
- the slide plate 423a can include an integral resilient locking finger 423h, cooperating with a locking structure/relief (e.g. retaining wall 419e) of the housing for releasably holding the slide plate 423a in each operating position.
- a locking structure 419e can be located e.g. at or near a proximal side of the housing (as in the drawings), and/or internally in the housing.
- the duo-dose slide plate 423a and particular its integral locking finger 423h, can be dimensioned such that it protrudes externally of the inhaler housing, to be operated by a user.
- a rear end of the inhaler housing (faced away from the mouthpiece 413) can include an opening or slit, e.g. defined between the bottom plate 419 and intermediate plate 418), allowing passage and transversal movement of the locking finger 423h.
- the respective slit can extend along the afore-mentioned retaining wall 419e, that e.g. can be located centrally, and that may optionally include slanted lateral sides for ease of locking finger operation.
- the top plate 417 and the bottom plate 419 of the housing are preferably interconnected via a plurality of integrated connectors 414a, for example click connectors and/or clamping studs 414a.
- the connectors 414a can be are arranged along a contour of the housing.
- the intermediate plate 418 can include connector passages or grooves 418a for passing the integrated connectors 414a between the top and bottom plates 417, 419, and for positioning the intermediate plate 418 with respect to the other plates of the stack.
- two of these connectors 414a are located at the rear side of the housing, in partial near opposite ends of the rear slit.
- a second pair of these connectors 414a is located relatively centrally or near the center of the housing (viewed in a longitudinal housing direction). Also, preferably a pair of the connectors 414a is located at or near a front side of the housing (near the mouth piece 413). In this way, a sturdy plate stack can be provided, allowing improved repositioning of the duo-dose compartment 423.
- Operation of the embodiment of Figures 6,7 is basically the same as that of the inhaler shown in Figures 3-5, with the difference that the dose-compartment can not be removed from the housing, but is positioned (and releasably locked by the locking finger 423h) into one of its two operation positions for discharge of a respective powder dose DI, D2.
- a user can transversally slide the slide plate 423a to its other operating position (upon handling the locking finger 423h), for discharging the other of the two doses DI, D2.
- the inhaler 401 can be discarded, and is preferably recycled.
- Figures 8A-8D depict a further example of an inhaler 501, that differs from the example of Figures 6, 7 in that the housing (only part being shown) includes a limited number of integrated connectors 514a, for example only four such connectors, that can be made e.g. in one piece with the bottom plate 519 of the housing (or alternatively the top plate of the housing). In this case, the housing does not have connectors located at the rear side of the housing. As a result, relatively compact inhaler assembly can be achieved. In particular, the inhaler can provide a relatively reduced rigidity at a back side of the housing, thereby improving sliding operation of the dose compartment 523.
- the housing includes a limited number of integrated connectors 514a, for example only four such connectors, that can be made e.g. in one piece with the bottom plate 519 of the housing (or alternatively the top plate of the housing).
- the housing does not have connectors located at the rear side of the housing.
- the inhaler can provide a relatively reduced rigidity at
- FIGS 8A, 8B Operation of this example is shown in Figures 8A, 8B and is basically the same as operation of the embodiment of Figures 6, 7.
- a first dose DI can be discharged, wherein air AF can enter the housing via the opening 519a extending below (and next to) the slide plate 523a, to be fed to one of the two downstream air channels 507b.
- Figures 9-12 schematically depict a further example of an inhaler 601, that differs from the above-described examples in that the planar dose compartment is provided by an array S (e.g. more than two) of separate dose reservoirs 623 (e.g. an elongated carrier strip having the dose reservoirs 623), the reservoirs 623 e.g. extending in-line with each other.
- the inhaler housing is configured such that the array S can be fed into and out of the housing of the inhaler, for example via opposite (left and right) sides of the housing, for subsequently bringing respective powder doses D into the dose region of the inhaler.
- the array S can slide with respect to the housing for removing the depleted reservoir out of the housing, and for positioning a subsequent dose reservoir or array (filled with powder D) into the dose region.
- Feeding of the array S into the housing is indicated by arrow F in Figure 10, whereas arrow G indicates removal of a used dose reservoir 623.
- a feeding direction F is perpendicular to the longitudinal axis of the inhaler housing.
- a strip (array S) of interconnected dose reservoirs 623 can be provided, to be fed into the inhaler housing.
- the dose reservoirs 623 of the array S are releasably connected to each other, e.g. via releasable connection structures 670, for example via intermediate weakening lines, tear-offlines, perforation lines and/or the like as will be clear to the skilled person.
- Each of the dose reservoirs 623 can have a rectangular shape (viewed in a top view).
- each planar dose compartment 623 includes a (flat) slide plate 623a having a (single) dose reservoir 623b (containing a dose D), wherein the or each reservoir 623b is preferably covered by a removable foil 624.
- the housing of the inhaler 601 of the present embodiment comprises a powder channel 607a extending through a powder dose supply region 608 of the inhaler 301 to the chamber 602, which powder channel 607a enters the chamber 302 substantially tangentially to its sidewall.
- the respective air circulation chamber (which is only schematically shown) has the same configuration as described above.
- the bottom plate 619 of the housing of the inhaler 601 can include a guide structure, in particular a depression providing opposite guide walls 619b (extending in parallel, perpendicular to the longitudinal axis of the inhaler housing), for receiving the array S of dose reservoirs and feeding a first one of the reservoirs to the dose region.
- a first lateral side of the housing can e.g. include an entry opening EO for entry of the array S of reservoirs 623, wherein a second lateral side that faces away from the first side can include a discharge opening XO for discharging used dose reservoirs 623.
- the inhaler 601 has releasable locking means 680 for releasably locking each planar dose compartment 623 of the array S to the housing when the dose compartment 623 is in a powder delivery position.
- the slide plate 623a of each of the dose compartments 623 can include an integral locking structure/relief, for cooperation with a stopper element (e.g. retaining element) 680 of the housing for releasably holding the slide plate 623a in its operating position.
- an operating part 680a of the stopper element 680 e.g. a knob
- a user preferably protrudes out of the housing of the inhaler 6302, to be operated by a user.
- the locking element 680 can be a resilient element 680 (e.g. a flexible beam, having a snapping relief for cooperating with the locking structures of the dose compartments 623) that can be moved from a locking position (shown in Figures 10, 11A) to a release position, preferably against an inherent spring force of the element 680, wherein the slide plate 623a can be removed from the inhaler housing when the locking element 680 is in a respective release position. Further, during placement of the strip S and respective slide plate 623a into the housing, the resilient locking element 680 can automatically snap into its depicted locking position, once the slide plate has reached its operation position.
- a resilient element 680 e.g. a flexible beam, having a snapping relief for cooperating with the locking structures of the dose compartments 623
- the resilient locking element 680 can be connected or coupled to e.g. the bottom plate 619 or intermediate plate of the inhaler housing via respective mounting means, for example one or more pins 680b that connect to pin receiving openings of the housing.
- these mounting means are located near the array entry opening EO of the housing.
- the inhaler housing can be configured to receive the dose compartment via a back side of the housing (as in Figures 3-4) or via a different side, e.g. via a lateral side of the housing.
- the inhaler can be configured in various ways for circulating air in or through the housing, in different air circulating directions (e.g. clockwise or counter clockwise).
- a location of the housing’s powder channel is not limited to the locations shown in the exemplary drawings.
- the powder channel can be located at a left or right side or e.g. in or near a middle of the housing of the inhaler (when viewed in a top view).
- the powder channel can have various shapes and various dimensions, as will be appreciated by the skilled person.
- the powder channel can be a straight channel, a curved channel, or a combination of such or other shapes.
- a said planar dose compartment e.g. a respective slide plate, can include a single dose reservoir for holding a single powder dose, two separate dose reservoirs for holding two respective powder doses, or more than two (e.g. three) dose reservoirs.
- the planar dose compartment can include an array (e.g. more than two) of separate dose reservoirs (e.g. a carrier strip having the dose reservoirs), wherein the inhaler housing is configured such that the array can be fed into and out of the housing of the inhaler, for example via opposite (left and right) sides of the housing, for subsequently bringing respective powder doses into the dose region of the inhaler. Then, after depletion (use) of one of the dose reservoirs, the array can slide with respect to the housing for removing the depleted reservoir out of the housing, and for positioning a subsequent dose reservoir or array (filled with powder) into the dose region.
- an array e.g. more than two
- separate dose reservoirs e.g. a carrier strip having the dose reservoirs
- a dose reservoir of a dose compartment can have various orientations and shapes.
- the dose reservoir in case of a substantially rectangular dose reservoir (when viewed in a top view), can extend substantially parallel with respect to a longitudinal axis MP of the inhaler, but that is not required.
- the dose reservoir extends at an angle (larger than 0 degrees) with respect to the longitudinal axis MP of the inhaler, e.g. an angle in the range of 10 - 45 degrees.
- the planar dose compartment is slidably received between the bottom plate and the intermediate plate, but that is not required.
- the planar dose compartment can be slidably received between the top plate and the intermediate plate.
- part of the dose compartment can protrude through the bottom plate of the inhaler housing (see Figure 5B, as an example).
- the dose compartment can be positioned in an upside-down orientation, and/or e.g. part of the dose compartment protrudes through a dedicated opening that can be provided in the intermediate plate of the inhaler housing.
- the slidable planar dose compartment can be substantially or entirely embedded in the housing of the inhaler.
- the slidable planar dose compartment can include a user operating member, e.g. a handle, knob, integral platelet section or the-like for manual manipulation of the planar dose compartment with respect to the inhaler’s housing.
- a user operating member e.g. a handle, knob, integral platelet section or the-like for manual manipulation of the planar dose compartment with respect to the inhaler’s housing.
- Such an operating member can e.g. protrude from the housing after assembly, in various directions, e.g. backwards (see Figures 3-8), downwards, or differently.
- the inhaler e.g. the housing
- the inhaler can be made of various materials, e.g. plastic(s), as will be appreciated by the skilled person.
- the inhaler is substantially or entirely made of biodegradable or bio-based material (e.g. biodegradable or bio-based plastic material).
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Nozzles (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2034384A NL2034384B1 (en) | 2023-03-20 | 2023-03-20 | Breath actuated dry powder inhaler |
| PCT/NL2024/050137 WO2024196247A1 (en) | 2023-03-20 | 2024-03-19 | Breath actuated dry powder inhaler |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4683692A1 true EP4683692A1 (en) | 2026-01-28 |
Family
ID=86657725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP24713587.4A Pending EP4683692A1 (en) | 2023-03-20 | 2024-03-19 | Breath actuated dry powder inhaler |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4683692A1 (en) |
| JP (1) | JP2026509561A (en) |
| KR (1) | KR20250162614A (en) |
| CN (1) | CN121079122A (en) |
| IL (1) | IL323418A (en) |
| NL (1) | NL2034384B1 (en) |
| WO (1) | WO2024196247A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026078074A1 (en) * | 2024-10-09 | 2026-04-16 | Vectura Delivery Devices Limited | Dry powder inhaler |
| WO2026078086A1 (en) * | 2024-10-09 | 2026-04-16 | Vectura Delivery Devices Limited | Dry powder inhaler |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1488819A1 (en) * | 2003-06-16 | 2004-12-22 | Rijksuniversiteit te Groningen | Dry powder inhaler and method for pulmonary inhalation of dry powder |
| WO2009046072A1 (en) * | 2007-10-02 | 2009-04-09 | Baxter International Inc | Dry powder inhaler |
| EP2944343A1 (en) * | 2014-05-15 | 2015-11-18 | AstraZeneca AB | Dry powder inhaler |
| PE20170080A1 (en) | 2014-06-06 | 2017-03-16 | Univ Groningen | BREATH ACTIVATED DRY POWDER INHALER |
-
2023
- 2023-03-20 NL NL2034384A patent/NL2034384B1/en active
-
2024
- 2024-03-19 EP EP24713587.4A patent/EP4683692A1/en active Pending
- 2024-03-19 CN CN202480031468.9A patent/CN121079122A/en active Pending
- 2024-03-19 JP JP2025555152A patent/JP2026509561A/en active Pending
- 2024-03-19 WO PCT/NL2024/050137 patent/WO2024196247A1/en not_active Ceased
- 2024-03-19 KR KR1020257034261A patent/KR20250162614A/en active Pending
-
2025
- 2025-09-17 IL IL323418A patent/IL323418A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024196247A1 (en) | 2024-09-26 |
| CN121079122A (en) | 2025-12-05 |
| IL323418A (en) | 2025-11-01 |
| JP2026509561A (en) | 2026-03-19 |
| NL2034384B1 (en) | 2024-09-26 |
| KR20250162614A (en) | 2025-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL323418A (en) | Breath actuated dry powder inhaler | |
| CA2529069C (en) | Dry powder inhaler and method for pulmonary inhalation of dry powder | |
| US5415162A (en) | Multi-dose dry powder inhalation device | |
| KR100218816B1 (en) | Powder inhaler | |
| US8550070B2 (en) | Powder inhaler | |
| ES2596263T3 (en) | Powder dispersion apparatus | |
| US7284553B2 (en) | Powder inhaler comprising a chamber for a capsule for taking up a non-returnable capsule being filled with an active ingredient | |
| CN106535968B (en) | Powder inhaler and powder inhalation set | |
| EP1283731B1 (en) | Medicament dispensing system with a medicament container with same side airflow inlet and outlet | |
| EP3284499B1 (en) | Dry powder inhaler with reproducible flow resistance | |
| RS20070011A (en) | Powder inhaler | |
| AU3188399A (en) | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament | |
| CA2509521C (en) | Powder inhaler with capsule chamber for receiving a disposable capsule filled with an active substance | |
| WO2008091355A2 (en) | Drug transfer device | |
| EP3151893B3 (en) | A breath actuated dry powder inhaler | |
| AU2015200705B2 (en) | Dry powder drug delivery system and methods | |
| JP2517780C (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20251008 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| P01 | Opt-out of the competence of the unified patent court (upc) registered |
Free format text: CASE NUMBER: UPC_APP_0011640_4683692/2026 Effective date: 20260331 |